[1] | Harvey KF, Pfleger CM, Hariharan IK. The Drosophila mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell, 2003, 114(4): 457-467. | [2] | Piccolo S, Dupont S, Cordenonsi M. The biology of YAP/TAZ: hippo signaling and beyond. Physiol Rev, 2014, 94(4): 1287-1312. | [3] | Hansen CG, Moroishi T, Guan KL. YAP and TAZ: a nexus for Hippo signaling and beyond. Trends Cell Biol, 2015, 25(9): 499-513. | [4] | Harvey K, Tapon N. The Salvador-Warts-Hippo pathway- an emerging tumour-suppressor network. Nat Rev Cancer, 2007, 7(3): 182-191. | [5] | Meng ZP, Moroishi T, Guan KL. Mechanisms of Hippo pathway regulation. Genes Dev, 2016, 30(1): 1-17. | [6] | Huang JB, Wu SA, Barrera J, Matthews K, Pan DJ. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP. Cell, 2005, 122(3): 421-434. | [7] | Zanconato F, Cordenonsi M, Piccolo S. YAP/TAZ at the roots of cancer. Cancer Cell, 2016, 29(6): 783-803. | [8] | Zeng Q, Hong WJ. The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals. Cancer Cell, 2008, 13(3): 188-192. | [9] | Zhao B, Wei XM, Li WQ, Udan RS, Yang Q, Kim J, Xie J, Ikenoue T, Yu JD, Li L, Zheng P, Ye KQ, Chinnaiyan A, Halder G, Lai ZC, Guan KL. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev, 2007, 21(21): 2747-2761. | [10] | Zhang X, George J, Deb S, Degoutin JL, Takano EA, Fox SB, AOCS Study group, Bowtell DDL, Harvey KF. The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene. Oncogene, 2011, 30(25): 2810-2822. | [11] | Steinhardt AA, Gayyed MF, Klein AP, Dong JX, Maitra A, Pan DJ, Montgomery EA, Anders RA. Expression of Yes-associated protein in common solid tumors. Hum Pathol, 2008, 39(11): 1582-1589. | [12] | Wang KN, Degerny C, Xu MH, Yang XJ. YAP, TAZ, Yorkie: a conserved family of signal-responsive transcriptional coregulators in animal development and human disease. Biochem Cell Biol, 2009, 87(1): 77-91. | [13] | Zhao B, Ye X, Yu JD, Li L, Li WQ, Li SM, Yu JJ, Lin JD, Wang CY, Chinnaiyan AM, Lai ZC, Guan KL. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev, 2008, 22(14): 1962-1971. | [14] | Chen Q, Zhang NL, Xie R, Wang W, Cai J, Choi KS, David KK, Huang B, Yabuta N, Nojima H, Anders RA, Pan DJ. Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP. Genes Dev, 2015, 29(12): 1285-1297. | [15] | |
[1] |
卢荆澳, 黄春燕, 林芷茵, 唐政, 马宁, 黄志斌. cd99l2基因调控斑马鱼白细胞组织间的迁移机制[J]. 遗传, 2022, 44(9): 798-809. |
[2] |
王翠玲, 刘信燚, 王亚会, 张争, 王治东, 周钢桥. MCM2通过抑制p53信号通路促进胆管癌细胞的增殖、迁移和侵袭[J]. 遗传, 2022, 44(3): 230-244. |
[3] |
吉新彦, 钟国轩, 赵斌. 哺乳动物Hippo信号通路分子机制研究进展[J]. 遗传, 2017, 39(7): 546-567. |
[4] |
王永煜,余薇,周斌. Hippo信号通路与心血管发育及疾病调控[J]. 遗传, 2017, 39(7): 576-587. |
[5] |
顾远, 张雷, 余发星. Hippo信号通路在肠道稳态、再生及癌变过程中的作用及机制[J]. 遗传, 2017, 39(7): 588-596. |
[6] |
李玉席, 李俊宏, 周大旺. Hippo信号通路与肝脏稳态调控及疾病发生[J]. 遗传, 2017, 39(7): 607-616. |
[7] |
姚传波, 周鑫, 陈策实, 雷群英. Hippo信号通路在乳腺癌中的调控机制及作用[J]. 遗传, 2017, 39(7): 617-629. |
[8] |
包笑妹, 何晴, 王莹, 黄智慧, 袁增强. Hippo/YAP信号通路在神经系统中的作用及机制研究进展[J]. 遗传, 2017, 39(7): 630-641. |
[9] |
许飞, 张进, 马端. Hippo/YAP和Wnt/β-catenin通路的对话[J]. 遗传, 2014, 36(2): 95-102. |
[10] |
谢树高, 谢银银, 张元亮,黄秋花. miR-145靶向调控DAB2对前列腺癌PC3细胞迁移和侵袭能力的影响[J]. 遗传, 2014, 36(1): 50-57. |
[11] |
门通 朴善花 滕春波. Hippo信号通路转录效应因子TAZ/YAP对间充质干细胞分化的调控[J]. 遗传, 2013, 35(11): 1283-1290. |
[12] |
谢翔,胡建军,王贵学. 生物力学——胚胎血管系统发育研究新视野[J]. 遗传, 2012, 34(9): 1123-1132. |
[13] |
李艳,王晓钰,王丽京,徐涛,卢晓晔,蔡冬青,耿建国,杨雪松. PTEN抑制胚胎原肠胚形成期EMT的过程[J]. 遗传, 2011, 33(6): 613-619. |
|